Publications database

Latest additions:
2026-03-05
14:17
DBCoverage [DKFZ-2026-00521] Journal Article
; ; ; et al
A brief feasibility report on an online psychosocial support intervention for adults with Li-Fraumeni syndrome.
Li-Fraumeni syndrome (LFS) is a rare autosomal dominant cancer predisposition syndrome characterized by a markedly elevated lifetime cancer risk. Despite the substantial psychological burden associated with LFS, tailored psychosocial interventions remain unavailable. [...]

Detailed record - Similar records
2026-03-05
14:14
DBCoverage [DKFZ-2026-00520] Journal Article
; ; ; et al
Clinical feasibility of accelerated whole liver water T1 mapping with T2*-compensation.
Current liver T1 mapping methods present restricted liver coverage, take long acquisition times and mostly exclude the T1 bias induced by fat and iron effects. We evaluated the clinical feasibility of an accelerated water T1 (wT1) mapping method, including all liver segments and the potential of its T2*-compensation (wT1comp) for fibrosis tissue assessment.Forty-three patients were classified into three groups: benign without/with risk of developing fibrosis and hepatocellular carcinoma (HCC). [...]

Detailed record - Similar records
2026-03-05
14:12
[DKFZ-2026-00519] Journal Article
; ; ; et al
Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat.
Managing aggressive meningiomas remains challenging because of limited treatment options besides surgical tumor removal and radiotherapy. To increase the repertoire of promising therapies for aggressive meningiomas, we established a multistep drug screening workflow, focusing on targetable genes obtained from transcriptome data of highly aggressive grade 3 meningiomas. [...]

Detailed record - Similar records
2026-03-05
14:08
DBCoverage [DKFZ-2026-00518] Journal Article
; ; ; et al
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, offering durable responses and prolonged survival. However, these therapies also present unique challenges, particularly with the onset of immune-related adverse events (irAEs), which can manifest during treatment either acutely and/or become chronic or emerge long after treatment cessation. [...]

Detailed record - Similar records
2026-03-05
14:06

Detailed record - Similar records
2026-03-05
14:05
[DKFZ-2026-00516] Journal Article
; ; ; et al
Pretherapeutic prognostic factors for survival under chemoimmunotherapy/immunotherapy of advanced NSCLC patients.
Checkpoint inhibitor therapy with PD-1/PD-L1-antibodies has significant benefits in non-small-cell lung cancer treatment even in advanced stage IVA/B. While PD-L1 expression in tumor is a weak but relevant predictor of treatment response, impact and interaction of potential prognostic factors like ECOG status, LDH-levels, CRP-levels, and genetic mutations remain so far undefined. [...]

Detailed record - Similar records
2026-03-05
14:03
[DKFZ-2026-00515] Journal Article
; ; ; et al
cIAP1 inhibitor of apoptosis is a tumor suppressor in Ewing sarcoma.
Ewing sarcoma (EwS) is a highly aggressive pediatric malignancy driven by EWSR1::ETS fusion oncoproteins -primarily EWSR1::FLI1- which deregulate genes essential for differentiation, proliferation, and cell survival. To uncover key downstream targets of this fusion involved in cell differentiation, we combined transcriptomic profiling of EwS cell lines following EWSR1::FLI1 inhibition with gene ontology analysis, a clinically annotated gene expression dataset derived from EwS patient material and network analyses. [...]

Detailed record - Similar records
2026-03-04
14:23
[DKFZ-2026-00514] Journal Article
; ; ; et al
7-T Potassium (39K) MRI to Assess Muscle K+ Depletion in Primary Aldosteronism.
Radiology 318(3), e252004 () [10.1148/radiol.252004]  GO
Background Although 98% of potassium (K+) resides intracellularly, current clinical diagnostics assess only extracellular K+ concentrations. Noninvasive imaging of tissue K+ distribution could provide novel insights into pathophysiologic processes in diseases such as primary aldosteronism (PA). [...]

Detailed record - Similar records
2026-03-04
14:19

Detailed record - Similar records
2026-03-04
14:16
[DKFZ-2026-00512] Journal Article
; ; ; et al
Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer.
Kisspeptins (KPs) and their receptor (KISS1R) promote metastasis and tumor progression in various cancers such as triple-negative breast cancer (TNBC). Targeting KISS1R holds great promise for molecular imaging and targeted radionuclide therapy of aggressively disseminated cancers. [...]

Detailed record - Similar records